A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)

Clinical trial NCT01782131 · COMPLETED

Trial details

NCT number: NCT01782131
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Fungal Infections Invasive Pulmonary Aspergillosis

Start date: 2013-09-25
Primary completion: 2019-07-10
Enrollment: 585

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.